Significance of Gleason grading of low-grade carcinoma of the prostate with therapeutic option of active surveillance
Autor: | Jens Köllermann, Burkhard Helpap, U. Oehler, Christian Fellbaum, Nicolas Wernert, Zaki Shaikhibrahim, Glen Kristiansen |
---|---|
Rok vydání: | 2012 |
Předmět: |
Oncology
Male medicine.medical_specialty Time Factors Urology Gleason grading urologic and male genital diseases Prostate Predictive Value of Tests Internal medicine medicine Carcinoma Humans Watchful Waiting Grading (tumors) Cell Nucleus Prostatectomy Chi-Square Distribution business.industry Patient Selection Prostatic Neoplasms medicine.disease Prognosis medicine.anatomical_structure Disease Progression Biopsy Large-Core Needle Neoplasm Grading business |
Zdroj: | Urologia internationalis. 90(1) |
ISSN: | 1423-0399 |
Popis: | Introduction: Active surveillance needs a precise grading diagnosis of a low-grade carcinoma of the prostate (Gleason score (GS) 6) within a small organ-confined tumor. However, how accurate is the gold standard of GS 6 in predicting a small pT2 carcinoma? To answer this question, we have analyzed grading systems in this study. Methods: Prostatic carcinomas in biopsy and corresponding radical prostatectomy (RP) specimens of 960 patients were graded by the Gleason system in which glandular fusions and nucleolar stage (prominence and location) were considered. Results: Using the modified Gleason grading, a high upgrading rate from the biopsy to RP specimens (GS 6–7) and in even 30% a non-organ-confined growth pattern (pT3) of GS 6 carcinoma in RP was found. When considering glandular fusion and the incorporation of the state of nucleoli within the Gleason grading, the agreement of score 6 between biopsy and RP specimens as well as the prediction of a pT2a tumor increased from about 80 to 90%. Conclusion: The combination of Gleason grading and grading of the nuclear and nucleolar features may help to identify patients eligible for active surveillance. |
Databáze: | OpenAIRE |
Externí odkaz: |